NCT03141489

Brief Summary

Malnutrition is highly prevalent among older adults. Adequate treatment is crucial to maintain health, improve functional status and independency. For severely malnourished patient, tube feeding is often the most effective treatment, but it also implies a risk of developing refeeding syndrome (RFS). RFS is described as fluid and electrolyte shifts particular hypophosphatemia when recommencing nutrition, potentially causing fatal complications. In 2006 National Institute for Health and Care Excellence (NICE) developed guidelines regarding 1) detecting patients at risk for RFS and 2) a treatment plan for refeeding severely malnourished patients. These guidelines have never been validated. Hence, there is a need to explore the use of different refeeding regimens in the treatment of older malnourished patients, in regards to assess safety, as well as the impact of the treatment, on functional status, independency, quality of life and RFS. This will be the first randomized controlled trial (RCT) that challenges the existing NICE guidelines. A blinded RCT study, with the aim of tube feeding patients at risk for developing RFS, and assigned either to an intervention group or to a control group, comparing the different refeeding regimens. This study will help develop safe and validated refeeding protocols for severely malnourished older patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 17, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

April 10, 2017

Completed
25 days until next milestone

First Posted

Study publicly available on registry

May 5, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 6, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 8, 2019

Completed
Last Updated

September 27, 2021

Status Verified

September 1, 2021

Enrollment Period

2.3 years

First QC Date

February 17, 2017

Last Update Submit

September 21, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Hand grip strength

    Using Jamar Pluss Digital +, Measuring change in kg from baseline, day 4, 7 and at 3months.

    Baseline and at three months.

Secondary Outcomes (8)

  • EQ-5D-5L

    Day 4 and after 3 months

  • Alertness, attention, acute change, and abbreviated mental test (The 4AT),

    Day 4 and after 3 months

  • Mortality

    register mortality after 3 months and 1-year

  • Readmission rates

    Readmissionrates after 30 days

  • Weight measurement

    Day 1, day 4 and on day 7 after staring with tubefeeding in hospital, and at 3 months

  • +3 more secondary outcomes

Study Arms (2)

NICE guidelines for refeeding syndrome

EXPERIMENTAL

High protein enteral tubefeeding solution. NICE guidelines regarding refeeding syndrome, based on a very cautious refeeding regime reaching estimated calorie and protein needs within 7 days, compared to a protocol at Diakonhjemmet Hospital using a higher starting rate, reaching estimated needs within 3 days.

Dietary Supplement: Tubefeeding

Diakonhjemmet Hospital Protocol(DS)

EXPERIMENTAL

High protein enteral tubefeeding solution. The intervention group, Diakonhjemmets feeding protocol, will start at 20 calories a kg a day, and increasing until estimated needs are met within 3days

Dietary Supplement: Tubefeeding

Interventions

TubefeedingDIETARY_SUPPLEMENT

NICE guidelines regarding refeeding syndrome, based on a very cautious refeeding regime reaching estimated calorie and protein needs within 7 days, compared to a protocol at Diakonhjemmet Hospital using a higher starting rate, reaching estimated needs within 3 days.

Also known as: fed by a feeding tube
Diakonhjemmet Hospital Protocol(DS)NICE guidelines for refeeding syndrome

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Malnourished: According to NICE screening tool:
  • BMI \<16kg/m2, or weight loss, or little nutritional intake, Or: BMI\< 18.5kg/m2, and; weight loss, or little nutritional intake, or alcohol, drug abuse, chemotherapy, antacids diuretics.

You may not qualify if:

  • Severe dementia (palliative stage).
  • Already on artificial nutrition
  • Terminal stage of life, defined as receiving only palliative medical treatment
  • Readmissions (patients will not be included twice)
  • Intensive care patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Diakonhjemmet Hospital

Oslo, Postboks 23 Vinderen, 0319, Norway

Location

Related Publications (1)

  • Olsen SU, Tazmini K, Aas AM, Ranhoff AH, Pripp AH, Hesseberg K, Sunde S, Bye A. The incidence and mortality of refeeding syndrome in older hospitalized patients, based on three different diagnostic criteria: A longitudinal study. Clin Nutr ESPEN. 2024 Jun;61:101-107. doi: 10.1016/j.clnesp.2024.03.006. Epub 2024 Mar 15.

MeSH Terms

Conditions

Refeeding Syndrome

Interventions

Enteral Nutrition

Condition Hierarchy (Ancestors)

MalnutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Feeding MethodsTherapeuticsNutritional SupportNutrition Therapy

Study Officials

  • Anette H Ranhoff, Professor

    Diakonhjemmet Hospital, Vinderen, Postboks 23, 0319 Oslo, Norway

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Patients and care provider(nurse) will be masked(not informed), Patients will be screened (height and weight) and handgrip strength will be performed by the investigator. Patients will sign a written consent, and then randomized to either the control or an intervention group. Patients will be tested on day 4, 7 and at 3 months by a research assistant/outcome assessor and is blinded treatment allocations. Blood tests are drawn daily. A nurse will administered the tubefeeding according to written orders in the medical journal; nurses are not informed about treatment allocation or the outcome measures. Physicians are informed about the study, but will not know what treatment patients will receive.
Purpose
SUPPORTIVE CARE
Intervention Model
FACTORIAL
Model Details: Refeeding protocol: Standardised refeeding protocols will be used for each of the patient groups; the control group will start tube feeding at 5 or 10 kcal/kg/day depending on their BMI and increase until needs are met within 7 days. The intervention group will start tube feeding at 20 kcal/kg/day and increase until needs are met within 3 days, but continue feeding minimum of 7days. Electrolytes will be monitored daily The patients will receive100 mg thiamine, and 1 multivitamin/mineral daily, all recorded in the medical journal. The intervention group will receive approximately 40% higher amount of protein and calories compared to the control group in the end of day 7.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Dietitian

Study Record Dates

First Submitted

February 17, 2017

First Posted

May 5, 2017

Study Start

April 10, 2017

Primary Completion

August 6, 2019

Study Completion

October 8, 2019

Last Updated

September 27, 2021

Record last verified: 2021-09

Locations